No...Ampyra is the "new" drug for increasing walking speed/distance. It's a reformulated drug that was available in compound and was approved by the FDA as the first drug specifically for a MS symptom.

The thread is about a clinical study run by Ely Lilly...seems to work to contain B cell activity, from what I remember. Neuro seems to think this will work against what he's been seeing in terms of my symptomology...